Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Abstract
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis. Chronic inflammatory processes affect all stages of tumour development as well as therapy. In this Review, we outline the principal cellular and molecular pathways that coordinate the tumour-promoting and tumour-antagonizing effects of inflammation and we discuss the crosstalk between cancer development and inflammatory processes. In addition, we discuss the recently suggested role of commensal microorganisms in inflammation-induced cancer and we propose that understanding this microbial influence will be crucial for targeted therapy in modern cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the intestinal microbiota can promote local inflammation and development of gastrointestinal cancers (Elinav et al., 2013; Garrett, 2015), it can exert an opposing effect on transplanted tumors at distal sites by priming the host immune system and enhancing the systemic anti-tumor immune response (Dzutsev et al., 2017).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Elinav et al., 2013
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Cited by
Items 701–800 of 1,001
Th1-Biased Immunomodulation and In Vivo Antitumor Effect of a Novel Piperine Analogue
Santos, J. A. F., Brito, M. T., Ferreira, R. C., Moura, A. P. G., de Sousa, T. K. G., Batista, T. M., Mangueira, V. M., Leite, F. C., da Cruz, R. M. D., Vieira, G. C., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092594 · Cited by 36
Yuan, S., Dong, Y., Peng, L., Yang, M., Niu, L., Liu, Z., & Xie, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10483 · Cited by 36
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Tredicine, M., Mucci, M., Recchiuti, A., & Mattoscio, D. (2025) · FEBS Letters · doi:10.1002/1873-3468.70013 · Cited by 35
Tanaka, N., Mizuno, R., Yasumizu, Y., Ito, K., Shirotake, S., Masunaga, A., Ito, Y., Miyazaki, Y. J., Hagiwara, M., Kanao, K., et al. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.10.001 · Cited by 35
Zhu, G., Tian, S., Wang, H., Ma, M.-G., Liu, Y., Du, H., & Long, Y. (2018) · Current Medical Science · doi:10.1007/s11596-018-1849-6 · Cited by 35
Lei, J., Wang, Y., Guo, X., Yan, S., Ma, D., Wang, P., Li, B., Du, W., Guo, R., & Kan, Q. (2020) · Future Oncology · doi:10.2217/fon-2019-0732 · Cited by 35
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
Anfossi, S., & Călin, G. A. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.04 · Cited by 35
Pu, F., Chen, F., Liu, J., Zhang, Z., & Shao, Z. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s298958 · Cited by 35
Li, C. M., & Chen, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.664305 · Cited by 35
Zhang, N., Liu, Y., Yang, H., Liang, M., Wang, X., Wang, M., Kong, J., Yuan, X., & Zhou, F. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609846 · Cited by 35
Mao, H., & Yang, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193962 · Cited by 35
Xu, J., Shi, K., Chen, B., Huang, Z., Lu, F., & Zhou, M. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13676 · Cited by 35
Su, D., Gao, Y.-Q., Dai, W., Hu, Y., Wu, Y., & Quanxi, M. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/5180707 · Cited by 35
Manzano, C. M., Bergamini, F. R. G., Lustri, W. R., Ruiz, A. L. T. G., de Oliveira, E. C. S., Ribeiro, M. A., Formiga, A. L. B., & Corbi, P. P. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.10.072 · Cited by 35
A Large-Cohort, Longitudinal Study Determines Precancer Disease Routes across Different Cancer Types
Hu, J. X., Helleberg, M., Jensen, A. B., Brunak, S., & Lundgren, J. D. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1677 · Cited by 35
Inflammasomes and the microbiota–partners in the preservation of mucosal homeostasis
Levy, M., Thaiss, C. A., Katz, M. N., Suez, J., & Elinav, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0451-7 · Cited by 34
“Together with more recent data [31], these studies indicate”
ResultSelf-citationTang, Y.-M., Cao, Q.-Y., Guo, X., Dong, S.-H., Duan, J., Wu, Q., & Liang, Q.-L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.047 · Cited by 34
Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action
Akter, Z., Ahmed, F. H., Tania, M., & Khan, M. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191011143642 · Cited by 34
Interleukin-38 in colorectal cancer: a potential role in precision medicine
Chen, F., Zhang, F., Tan, Z., Hambly, B. D., Bao, S., & Tao, K. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02440-7 · Cited by 34
Topkan, E., Mertsoylu, H., Küçük, A., Beşen, A. A., Sezer, A., Sezen, D., Bölükbaşı, Y., Selek, U., & Pehlivan, B. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/5701949 · Cited by 34
Jiang, A., Zhao, R., Liu, N., Ma, Y., Ren, M., Tian, T., & Yao, Y. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1739 · Cited by 34
Leenen, S., Hermens, M., van Steenwijk, P. J. D. V., Bekkers, R. L. M., & van Esch, E. M. G. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02831-1 · Cited by 34
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma
Nurmi, A. M., Mustonen, H. K., Stenman, U., Seppänen, H. E., & Haglund, C. H. (2021) · Scientific Reports · doi:10.1038/s41598-020-80778-0 · Cited by 34
Feng, J., Wang, L., Yang, X., Chen, Q., & Cheng, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110805 · Cited by 34
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in gorlin syndrome
Chaudhary, S. C., Tang, X., Arumugam, A., Li, C., Srivastava, R. K., Weng, Z., Xu, J., Zhang, X., Kim, A. L., McKay, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5103 · Cited by 34
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Flores‐Borja, F., Irshad, S., Gordon, P., Wong, F., Sheriff, I., Tutt, A. N. J., & Ng, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/7803091 · Cited by 34
Del-1 overexpression potentiates lung cancer cell proliferation and invasion
Lee, S. H., Kim, D.-Y., Jing, F., Kim, H., Yun, C., Han, D. J., & Choi, E. Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.159 · Cited by 34
Inflammation by Breast Implants and Adenocarcinoma: Not Always a Bad Company
Orciani, M., Sorgentoni, G., Olivieri, F., Mattioli‐Belmonte, M., Benedetto, G. D., & Primio, R. D. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.01.001 · Cited by 33
Okugawa, Y., Ohi, M., Kitajima, T., Higashi, K., Sato, Y., Yamashita, S., Uratani, R., Shimura, T., Imaoka, H., Kawamura, M., et al. (2024) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2024.04.016 · Cited by 33
Clark, M. L., Simeonov, K. P., Mowel, W. K., Michieletto, M. F., Joannas, L. D., Wright, J. M., Erickson, I., Johnson, L. R., Krishnan, R., de la Fuente‐Núñez, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.006 · Cited by 33
Khatri, M., Bello, D., Martin, J., Bello, A., Gore, R. J., Demokritou, P., & Gaines, P. C. W. (2017) · NanoImpact · doi:10.1016/j.impact.2017.01.007 · Cited by 33
Penrose, H. M., Cable, C., Heller, S., Ungerleider, N., Nakhoul, H. N., Baddoo, M., Hartono, A. B., Lee, S. B., Burow, M. E., Flemington, E. F., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.003 · Cited by 33
Application of Anti-Inflammatory Agents in Prostate Cancer
Hatano, K., Fujita, K., & Nonomura, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082680 · Cited by 33
Zhang, Y., Niu, J., Wu, H.-W., Si, X., Zhang, S., Li, D., Bian, T., Li, Y., & Yan, X. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/6692811 · Cited by 33
Shi, W., Men, L., Pi, X., Jiang, T., Peng, D., Huo, S., Luo, P., Wang, M., Guo, J., Jiang, Y., et al. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5279 · Cited by 33
Redrawing therapeutic boundaries: microbiota and cancer
Sholl, J., Sepich‐Poore, G. D., Knight, R. D., & Pradeu, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.008 · Cited by 33
Opioids in cancer: The κ‑opioid receptor (Review)
Zhou, Q., Zhang, Z., Long, S., Li, W., Wang, B., & Liang, N. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12560 · Cited by 33
Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246
Zhou, X., Sanz, G., Zhan, Y., Oliveira, M. M. S., Rezaei, S., Singh, M., Peuget, S., Westerberg, L. S., Johnsen, J. I., & Selivanova, G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01971-8 · Cited by 33
Lu, J., Song, Z.-J., Cai, F., Ruan, L.-J., & Jiang, R. (2022) · Molecules · doi:10.3390/molecules28010302 · Cited by 33
Zeng, X. Y., Yang, M., Ye, T., Feng, J., Xu, X., Hua-an, Y., Wang, X., Bao, L., Li, R. Q., Xue, B., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.024 · Cited by 33
Adenosine, bridging chronic inflammation and tumor growth
Chen, L., Alabdullah, M., & Mahnke, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258637 · Cited by 33
Takikawa, T., Kikuta, K., Sano, T., Ikeura, T., Fujimori, N., Umemura, T., Naitoh, I., Nakase, H., Isayama, H., Kanno, A., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.01.008 · Cited by 33
Maeda, Y., Echizen, K., Oshima, H., Yu, L., Sakulsak, N., Hirose, O., Yamada, Y. M. A., Taniguchi, T., Jenkins, B. J., Saya, H., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0315 · Cited by 33
Liang, Y., Xiao, W., Guan, Y., Wang, W., Chen, H. Y., Fang, C., Zhang, X., & Zhou, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.20990 · Cited by 33
S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling
Kumar, A., Zamora-Pineda, J. B., Degagné, É., & Saba, J. D. (2017) · Mediators of Inflammation · doi:10.1155/2017/7685142 · Cited by 33
Shen, Y., Wang, H., Chen, X., Li, W., & Chen, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s217935 · Cited by 33
Li, S., Feng, X., Cao, G., Wang, Q., & Wang, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230879 · Cited by 33
Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms
Ben-Shmuel, S., Rostoker, R., Scheinman, E. J., & LeRoith, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_12 · Cited by 33
Padilla‐Banks, E., Jefferson, W. N., Papas, B. N., Suen, A. A., Xu, X., Carreon, D. V., Willson, C. J., Quist, E. M., & Williams, C. J. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002334 · Cited by 32
Genistein: A promising phytoconstituent with reference to its bioactivities
Shete, V., Mahajan, N. M., Shivhare, R. S., Akkewar, A. S., Gupta, A., & Gurav, S. S. (2024) · Phytotherapy Research · doi:10.1002/ptr.8256 · Cited by 32
Ma, P., Yuan, L., Jia, S., Zhou, Z., Xu, D., Huang, S., Meng, F., Zhang, Z., & Nan, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1446328 · Cited by 32
Tao, J., Gu, Y., Zhang, Z., Weng, G., Liu, Y., Ren, J., Shi, Y., Qiu, J., Wang, Y., Su, D., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03201-w · Cited by 32
Zhang, M., Gong, W., Zuo, B., Chu, B., Tang, Z., Zhang, Y., Yang, Y., Zhou, D., Weng, M., Qin, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12693 · Cited by 32
Dong, W., Liu, Z., Sun, L., Wang, C., Guan, Y., Mao, X., & Shang, D. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.025 · Cited by 32
Wang, C., Zhao, K., Hu, S., Huang, Y., Ma, L., Song, Y., & Li, M. (2020) · BMC Cancer · doi:10.1186/s12885-020-07040-8 · Cited by 32
Fu, S., Jin, Y., Tan, Y., & Liu, D. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-252 · Cited by 32
Buhrmann, C., Brockmueller, A., Harsha, C., Kunnumakkara, A. B., Kubatka, P., Aggarwal, B. B., & Shakibaei, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.699842 · Cited by 32
Xie, Z., Zhou, H., Wang, L., & Wu, Y. (2022) · PeerJ · doi:10.7717/peerj.13091 · Cited by 32
Intratumoral microbiota: new frontiers in tumor immunity
Zhang, Z., Liao, Y., & Tang, D. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac063 · Cited by 32
Tada, T., Kumada, T., Hiraoka, A., Kariyama, K., Tani, J., Hirooka, M., Takaguchi, K., Atsukawa, M., Fukunishi, S., Itobayashi, E., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5495 · Cited by 32
Elechi, J. O. G., Sirianni, R., Conforti, F. L., Cione, E., & PELLEGRINO, M. A. (2023) · Foods · doi:10.3390/foods12122286 · Cited by 34
Campesato, L. F., Silva, A. P. M., Cordeiro, L., Corrêa, B., Navarro, F. C. P., Zanin, R. F., Marçola, M., Inoue, L. T., Duarte, M. L., Molgora, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17713 · Cited by 32
Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure
Dragani, T. A., Colombo, F., Pavlisko, E. N., & Roggli, V. L. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy089 · Cited by 32
Patel, R., Palit, S. P., RATHWA, N. N., Ramachandran, A. V., & Begum, R. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.962 · Cited by 32
Wang, Y., Liu, S., Li, B., Jiang, Y., Zhou, X., Chen, J., Li, M., Ren, B., Peng, X., Zhou, X., et al. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1643205 · Cited by 32
Xue, Y., & Li, G. (2020) · Bioscience Reports · doi:10.1042/bsr20200352 · Cited by 32
Štěpáníková, I., Oates, G. R., & Bateman, L. B. (2016) · Ethnicity and Health · doi:10.1080/13557858.2016.1235681 · Cited by 32
Immunological aspect of the liver and metastatic uveal melanoma
Terai, M., Mastrangleo, M. J., & Sato, T. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.39 · Cited by 31
Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa
Campanati, A., Orciani, M., Sorgentoni, G., Consales, V., Offidani, A., & Primio, R. D. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.2516 · Cited by 31
Norde, M. M., Fisberg, R. M., Marchioni, D. M. L., & Rogero, M. M. (2019) · Nutrition · doi:10.1016/j.nut.2019.110596 · Cited by 31
Gotland, N., Hansen, M.-L. U., Sandholdt, H., Mejer, N., Lundbo, L. F., Petersen, A., Larsen, A. R., & Benfield, T. (2020) · Medicine · doi:10.1097/md.0000000000019984 · Cited by 31
Luo, X., Yu, Z., Yue, B., Ren, J., Zhang, J., Mani, S., Wang, Z., & Dou, W. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1812673 · Cited by 31
Impact of inflammation and immunotherapy in renal cell carcinoma (Review)
Shi, J., Wang, K., Xiong, Z., Yuan, C., Wang, C., Cao, Q., Huang, Y., Meng, X., Xie, K., Cheng, Z., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12135 · Cited by 31
Managing Cancer Drug Resistance from the Perspective of Inflammation
Lu, S., Li, Y., Zhu, C., Wang, W., & Zhou, Y. (2022) · Journal of Oncology · doi:10.1155/2022/3426407 · Cited by 31
Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
Xu, X., & Jing, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.900305 · Cited by 31
Bladder cancer-associated microbiota: Recent advances and future perspectives
Zhang, W., Yang, F., Mao, S., Wang, R., Chen, H., Ran, Y., Liu, S., Wu, P., Yan, Y., Li, W., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13012 · Cited by 31
Novel pathophysiological insights into CAR-T cell associated neurotoxicity
Genoud, V., & Migliorini, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1108297 · Cited by 31
Topkan, E., Somay, E., Yılmaz, B., Pehlivan, B., & Selek, U. (2023) · BMC Cancer · doi:10.1186/s12885-023-11155-z · Cited by 31
Leodolter, A., Alonso, S., González, B., Ebert, M. P., Vieth, M. W., Röcken, C., Wex, T., Peitz, U., Malfertheiner, P., & Perucho, M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.14 · Cited by 32
Таширева, Л. А., Михайлович, П. В., Манских, В. Н., Denisov, E. V., Savelieva, O. E., Кайгородова, Е. В., & Zavyalova, M. V. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917050029 · Cited by 31
The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Lee, C. W., Baek, J., & Han, S. (2017) · Molecules · doi:10.3390/molecules22091411 · Cited by 31
Why target the tumor stroma in melanoma?
Hutchenreuther, J., & Leask, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0419-1 · Cited by 31
Steptoe, A., Ronaldson, A., Kostich, K., Lazzarino, A. I., Urbanova, L., & Carvalho, L. A. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.027 · Cited by 31
IL-17A-producing T cells are associated with the progression of lung adenocarcinoma
Bao, Z., Lu, G., Cui, D., Yao, Y., Yang, G., & Zhou, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4837 · Cited by 30
“In addition, inflammation compromises genomic maintenance and repair pathways, inducing genomic instability (6,9).”
BackgroundInfluentialSpirito, F. D., Folliero, V., Palo, M. P. D., Benedetto, G. D., Aulisio, L., Martina, S., Rinaldi, L., & Franci, G. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16090332 · Cited by 30
Vitale, G., Dicitore, A., Barrea, L., Sbardella, E., Razzore, P., Campione, S., Faggiano, A., Colao, A. A. L., on behalf of, N. I. K. E., Albertelli, M., et al. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09589-y · Cited by 30
The role of gut microbiota in the development of colorectal cancer: a review
Koyande, N. P., Gangopadhyay, M., Thatikonda, S., & Rengan, A. K. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04192-w · Cited by 30
Rajai, N., Ahmad, A., Toya, T., Sara, J. D. S., Herrmann, J., Lerman, L. O., & Lerman, A. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac184 · Cited by 30
Ye, K., Xiao, M., Li, Z., He, K., Wang, J., Zhu, L., Xiong, W., Zhong, Z., & Tang, Y. (2022) · Cancer Medicine · doi:10.1002/cam4.5284 · Cited by 30
Triamchaisri, N., Toochinda, P., & Lawtrakul, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021525 · Cited by 30
Curcumolide, a unique sesquiterpenoid with anti-inflammatory properties from Curcuma wenyujin
Dong, J., Shao, W., Yan, P., Cai, X., Fang, L., Zhao, X., Lin, W., & Cai, Y. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.075 · Cited by 30
Lauro, G., Manfra, M., Pedatella, S., Fischer, K., Cantone, V., Terracciano, S., Bertamino, A., Ostacolo, C., Gomez-Monterrey, I. M., Nisco, M. D., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.042 · Cited by 30
Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
Wu, S., Zhou, Y., Hua, H.-Y., Zhang, Y., Zhu, W., Wang, Z.-Q., Li, J., Gao, H.-Q., Wu, X., Lu, T., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4914-4 · Cited by 30
de Baumont, A., Bortoluzzi, A., de Aguiar, B. W., Scotton, E., Guimarães, L. S. P., Kapczinski, F. P., da Silva, C. T. B., & Manfro, G. G. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.011 · Cited by 30
Ahmed, M., Jinks, N., Babaei‐Jadidi, R., Kashfi, H., Castellanos‐Uribe, M., May, S. T., Mukherjee, A., & Nateri, A. S. (2019) · Cancers · doi:10.3390/cancers12010106 · Cited by 31
A Role for MAIT Cells in Colorectal Cancer
Berzins, S. P., Wallace, M. E., Kannourakis, G., & Kelly, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00949 · Cited by 30
A Perspective Discussion on Rising Pesticide Levels and Colon Cancer Burden in Brazil
Uyemura, S. A., Stopper, H., Martin, F. L., & Kannen, V. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00273 · Cited by 30
Teng, Y., Xie, R., Xu, J., Wang, P., Chen, W., Shan, Z., Yan, Z., Mao, F., Cheng, P., Peng, L., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01055-4 · Cited by 29
Microbial mysteries: Staphylococcus aureus and the enigma of carcinogenesis
Odunitan, T. T., Apanisile, B. T., Akinboade, M. W., Abdulazeez, W. O., Oyaronbi, A. O., Ajayi, T. M., Oyekola, S. A., Ibrahim, N. O., Nafiu, T., Afolabi, H. O., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106831 · Cited by 29
A New Prognostic Index in Young Breast Cancer Patients
Demir, H., Demirci, A., Eren, S. K., Beypınar, İ., Davarcı, S. E., & Baykara, M. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.01.86 · Cited by 29
Metadata
- Authors
- Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A.
- Affiliations
- Weizmann Institute of Science (IL)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Elinav, Eran
- Flavell, Richard A.
- Venue
- Nature reviews. Cancer
- Published
- 2013-10-24
- Volume
- 13
- Issue
- 11
- Pages
- 759-771
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2143841612
- Cited by
- 2,000
- References
- 154
- Citations by year
- 2026: 83 · 2025: 150 · 2024: 223 · 2023: 167 · 2022: 204 · 2021: 187 · 2020: 202 · 2019: 132 · 2018: 144 · 2017: 149 · 2016: 142 · 2015: 124 · 2014: 90 · 2013: 2
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammation-associated tumorigenesis, chronic inflammation, tumor progression, tumor microenvironment, gut microbiota, commensal microorganisms, innate immunity, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Homeostasis, Humans, Immunity, Innate, Inflammation, Neoplasm Metastasis, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Cell Proliferation, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.